Integra Lifesciences Holdings (IART) Non-Current Debt (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Non-Current Debt of $1.7 billion for Q2 2026, down 0.81% sequentially from $1.8 billion in Q1 2026, and up 55.27% YoY from $1.1 billion in Q2 2025.
Integra Lifesciences Holdings (IART) Non-Current Debt (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Non-Current Debt for 18 years, with the latest figure at $1.7 billion in Q2 2026.
- Quarterly Non-Current Debt rose 55.27% year-over-year to $1.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.7 billion (up 55.27% YoY) and the FY2025 annual result came in at $1.7 billion, up 58.98% from the prior year.
- Non-Current Debt retreated to $1.7 billion in Q2 2026 per IART's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $1.8 billion in Q1 2026 and troughed at $733.1 million in Q4 2022.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt decreased 11.05% in 2022, then surged 58.98% in 2025.
- Over 5 years, Non-Current Debt stood at $733.1 million in 2022, then increased by 12.61% to $825.6 million in 2023, then surged by 31.78% to $1.1 billion in 2024, then surged by 58.98% to $1.7 billion in 2025, then advanced by 0.38% to $1.7 billion in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $1.7 billion, $1.8 billion, and $1.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 1.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Bn |
| Mar 31, 2026 | 1.75 Bn |
| Dec 31, 2025 | 1.73 Bn |
| Sep 30, 2025 | 1.71 Bn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 1.13 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.15 Bn |
| Mar 31, 2024 | 1.17 Bn |
| Dec 31, 2023 | 825.56 Mn |
| Sep 30, 2023 | 850.09 Mn |
| Jun 30, 2023 | 775.00 Mn |
| Mar 31, 2023 | 775.00 Mn |
| Dec 31, 2022 | 733.15 Mn |
| Sep 30, 2022 | 814.53 Mn |
| Jun 30, 2022 | 821.25 Mn |
| Mar 31, 2022 | 832.50 Mn |
| Dec 31, 2021 | 824.26 Mn |
| Sep 30, 2021 | 855.00 Mn |